190 related articles for article (PubMed ID: 20012317)
1. Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy.
Yeh CN; Jung SM; Chen TW; Hwang TL; Jan YY; Chen MF
Langenbecks Arch Surg; 2010 Mar; 395(3):217-25. PubMed ID: 20012317
[TBL] [Abstract][Full Text] [Related]
2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
3. Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients.
Tsujitani S; Konishi I; Suzuki K; Oka S; Gomyo Y; Matsumoto S; Hirooka Y; Kaibara N
J Exp Clin Cancer Res; 2000 Jun; 19(2):189-95. PubMed ID: 10965817
[TBL] [Abstract][Full Text] [Related]
4. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.
Hu YC; Komorowski RA; Graewin S; Hostetter G; Kallioniemi OP; Pitt HA; Ahrendt SA
Clin Cancer Res; 2003 Sep; 9(11):4165-71. PubMed ID: 14519641
[TBL] [Abstract][Full Text] [Related]
6. Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Choi J; Lim H; Nam DK; Kim HS; Cho DY; Yi JW; Kim HC; Cho YK; Kim MW; Joo HJ; Lee KB; Kim KB
Br J Cancer; 2001 Jan; 84(2):186-92. PubMed ID: 11161374
[TBL] [Abstract][Full Text] [Related]
7. Correlation between expression of thymidylate synthase and clinical outcome of advanced gastric cancer treated with capecitabine alone chemotherapy.
Liu XF; Zhang H; Sun JQ; Yin C; Liu TF; Yang H; Chen LH
Tumour Biol; 2014 Dec; 35(12):12409-14. PubMed ID: 25185651
[TBL] [Abstract][Full Text] [Related]
8. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Terashima M; Fujiwara H; Takagane A; Abe K; Irinoda T; Nakaya T; Yonezawa H; Oyama K; Saito K; Kanzaki N; Ohtani S; Nemoto T; Hoshino Y; Kogure M; Gotoh M
Gastric Cancer; 2003; 6 Suppl 1():71-81. PubMed ID: 12775024
[TBL] [Abstract][Full Text] [Related]
9. Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.
Hua D; Huang ZH; Mao Y; Deng JZ
World J Gastroenterol; 2007 Oct; 13(37):5030-4. PubMed ID: 17854149
[TBL] [Abstract][Full Text] [Related]
10. Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.
Hitre E; Budai B; Adleff V; Czeglédi F; Horváth Z; Gyergyay F; Lövey J; Kovács T; Orosz Z; Láng I; Kásler M; Kralovánszky J
Pharmacogenet Genomics; 2005 Oct; 15(10):723-30. PubMed ID: 16141798
[TBL] [Abstract][Full Text] [Related]
11. Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.
Choi JH; Lim HY; Joo HJ; Kim HS; Yi JW; Kim HC; Cho YK; Kim MW; Lee KB
Br J Cancer; 2002 May; 86(10):1578-85. PubMed ID: 12085207
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
Johnston PG; Mick R; Recant W; Behan KA; Dolan ME; Ratain MJ; Beckmann E; Weichselbaum RR; Allegra CJ; Vokes EE
J Natl Cancer Inst; 1997 Feb; 89(4):308-13. PubMed ID: 9048835
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Cirqueira CDS; de Mello ES; Zilberstein B; Alves VAF; Ribeiro U
Chin J Cancer Res; 2018 Oct; 30(5):526-536. PubMed ID: 30510364
[TBL] [Abstract][Full Text] [Related]
14. High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy.
Yeh KH; Shun CT; Chen CL; Lin JT; Lee WJ; Lee PH; Chen YC; Cheng AL
Cancer; 1998 May; 82(9):1626-31. PubMed ID: 9576280
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer with microsatellite instability displays increased thymidylate synthase expression.
Pereira MA; Dias AR; Ramos MFKP; Cardili L; Moraes RDR; Zilberstein B; Nahas SC; Mello ES; Ribeiro U
J Surg Oncol; 2022 Jul; 126(1):116-124. PubMed ID: 35689583
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of thymidylate synthase in advanced gastric cancer: a prognostic indicator in patients undergoing gastrectomy followed by adjuvant chemotherapy with 5-fluoropyrimidines.
Suda Y; Kuwashima Y; Tanaka Y; Uchida K; Akazawa S
Anticancer Res; 1999; 19(1B):805-10. PubMed ID: 10216496
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
[TBL] [Abstract][Full Text] [Related]
18. Implication of thymidylate synthase in the outcome of patients with invasive ductal carcinoma of the pancreas and efficacy of adjuvant chemotherapy using 5-fluorouracil or its derivatives.
Takamura M; Nio Y; Yamasawa K; Dong M; Yamaguchi K; Itakura M
Anticancer Drugs; 2002 Jan; 13(1):75-85. PubMed ID: 11914644
[TBL] [Abstract][Full Text] [Related]
19. Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy.
Lee J; Park CK; Park JO; Lim T; Park YS; Lim HY; Lee I; Sohn TS; Noh JH; Heo JS; Kim S; Lim DH; Kim KM; Kang WK
Clin Cancer Res; 2008 Jan; 14(1):82-8. PubMed ID: 18172256
[TBL] [Abstract][Full Text] [Related]
20. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
